Literature DB >> 30974444

Extracorporeal Blood Purification Therapies for Sepsis.

Céline Monard1,2, Thomas Rimmelé3,4, Claudio Ronco5,6,7.   

Abstract

Extracorporeal blood purification is proposed as an adjuvant therapy for sepsis, aiming at controlling the associated dysregulation of the immune system, which is known to induce organ dysfunctions. Different therapies have been developed to address certain steps of the immune dysregulation. Most of the available blood purification devices focus on a single target, such as the endotoxin that triggers the immune cascade, or the cytokine storm that causes organ damages. However, the highly adsorptive membrane named oXiris® is a unique 4-in-1 device that combines cytokine and endotoxin removal properties, renal replacement function, and antithrombogenic properties. More recently, promising treatments that focus on the pathogen itself or the immune cells have been developed and are currently under investigation. In this review, we aim to summarize, according to their target, the different extracorporeal blood purification techniques that are already available for use. We will also briefly introduce the most recent techniques that are still under development. Because of its unique ability to remove both endotoxins and cytokines, we will particularly discuss the highly adsorptive preheparinized oXiris® membrane. We will present its properties, advantages, pitfalls, as well as therapeutic perspectives based on experimental and clinical data. Video Journal Club "Cappuccino with Claudio Ronco" at  https://www.karger.com/Journal/ArticleNews/223997?sponsor=52.
© 2019 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Adsorption; Blood purification therapy; Precision medicine; Renal replacement therapy; Sepsis

Mesh:

Substances:

Year:  2019        PMID: 30974444     DOI: 10.1159/000499520

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  28 in total

1.  [Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?]

Authors:  Enrique A Florit; Fritz Diekmann
Journal:  Nefrologia       Date:  2020-05-23       Impact factor: 2.033

Review 2.  Sepsis 2019: What Surgeons Need to Know.

Authors:  Vanessa P Ho; Haytham Kaafarani; Rishi Rattan; Nicholas Namias; Heather Evans; Tanya L Zakrison
Journal:  Surg Infect (Larchmt)       Date:  2019-11-22       Impact factor: 2.150

3.  Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.

Authors:  Ali Esmaeili Vardanjani; Claudio Ronco; Hossein Rafiei; Mohamad Golitaleb; Mohammad Hoseyn Pishvaei; Mostafa Mohammadi
Journal:  Blood Purif       Date:  2020-06-26       Impact factor: 2.614

Review 4.  Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?

Authors:  Mikhail Kiselevskiy; Irina Shubina; Irina Chikileva; Suria Sitdikova; Igor Samoylenko; Natalia Anisimova; Kirill Kirgizov; Amina Suleimanova; Tatyana Gorbunova; Svetlana Varfolomeeva
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-26

Review 5.  Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: a case report and literature review.

Authors:  Yining Li; Linshan Zhou; Lingzhi Yang; Fang Yuan
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

6.  Bioassay for Endothelial Damage Mediators Retrieved by Hemoadsorption.

Authors:  Maximilian Denzinger; Ludger Staendker; Keno Ehlers; Julian M Schneider; Tanja Schulz; Tabea Hein; Sebastian Wiese; Annika Roecker; Ruediger Gross; Jan Münch; Hendrik Bracht; Eberhard Barth; Manfred Weiss; Michael Georgieff; E Marion Schneider
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.

Authors:  Rodney Alexander Rosalia; Petar Ugurov; Dashurie Neziri; Simona Despotovska; Emilija Kostoska; Lidija Veljanovska-Kiridjievska; Dimche Kuzmanov; Aleksandar Trifunovski; Dijana Popevski; Gianluca Villa; Zan Mitrev
Journal:  Blood Purif       Date:  2021-06-14       Impact factor: 2.614

Review 8.  Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.

Authors:  Tuğçe Nur Yiğenoğlu; Turgay Ulas; Mehmet Sinan Dal; Serdal Korkmaz; Mehmet Ali Erkurt; Fevzi Altuntaş
Journal:  Transfus Apher Sci       Date:  2020-06-25       Impact factor: 2.596

9.  Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.

Authors:  Jie Ma; Peng Xia; Yangzhong Zhou; Zhengyin Liu; Xiang Zhou; Jinglan Wang; Taisheng Li; Xiaowei Yan; Limeng Chen; Shuyang Zhang; Yan Qin; Xuemei Li
Journal:  Clin Immunol       Date:  2020-04-01       Impact factor: 3.969

Review 10.  Multiscale Biofluidic and Nanobiotechnology Approaches for Treating Sepsis in Extracorporeal Circuits.

Authors:  Joo H Kang
Journal:  Biochip J       Date:  2020-03-12       Impact factor: 4.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.